InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by ROCHE ROBERT P JR, Director. Officer active across 1 company, notably Antares Pharma, INC.. Cumulatively, 3 filings have been published. History available since 10 June 2021. The latest transaction was disclosed on 24 May 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Robert P. Roche Jr. is a Director at Antares Pharma, Inc. He plays a key role in the governance and strategy of the company, bringing his expertise in the pharmaceutical sector. His role on the board is essential in guiding strategic decisions.